 The COVID-19 pandemic has caused a significant disruption to the delivery of secondary prevention measures in patients with established atherosclerotic cardiovascular disease, CVD. To address this issue, healthcare providers have had to rapidly adopt new medical services, such as telemedicine, to ensure continuity of care. This study examined the impact of the pandemic on secondary prevention in patients who underwent coronary artery bypass grafting, cabbed, and evaluated the effectiveness of telemedicine for implementing lifestyle change measures, remote monitoring, and treatment regimen adjustments. The study found that the use of telemedicine allowed for continued patient care and adjustments to medication and counseling, especially during the second year of the pandemic. This article was authored by Luminina Eliuda, Andrea Gabriela Andronisi, Marius Racalbu, and others.